TGFβ1 signaling in primary fibroblasts
Corresponding Organization :
Other organizations : Hôtel-Dieu de Québec, Université Laval
Variable analysis
- Treatment with media only (untreated)
- Treatment with 10 ng/mL rhTGFβ1
- Treatment with 10 ng/mL rhTGFβ1 + 10 µM Galunisertib
- Treatment with recombinant human TGFβ1 at indicated concentration
- Total RNA extracted for RNA-seq analysis
- IL-6 protein levels in the supernatant
- Cell proliferation measured by CellTiter-Glo® assay
- Primary normal fibroblast cell lines: PHBF (Bladder), CCD-18Co (Colon), and HOF (Ovary)
- Serum starvation overnight prior to treatment
- Treatment duration: 24 h for RNA-seq, 48 h for IL-6 protein, and 72 h for proliferation assay
Annotations
Based on most similar protocols
As authors may omit details in methods from publication, our AI will look for missing critical information across the 5 most similar protocols.
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!